INDIA IPO
  • Home
  • About
    • About us
    • Our CSR
  • Services

    IPO

    • Initial Public Offering (IPO)
    • SME IPO Consultation
    • Mainline IPO Consultation
    • Follow-On Public Offer (FPO)
    • Pre-IPO Funding Consultants

    Capital Raising

    • Social Stock Exchange
    • Private Placement
    • Project Funding
    • REIT
    • SM REIT
    • Rights Issue Advisory
    • InvIT Rights Issue
    • InvIT Public Issue
    • InvIT Private Issue
    • Debt Syndication
    • Securitised Debt Instruments
    • Public Municipal Debt
    • Private Municipal Debt

    Finance Advisory

    • Business Valuation
    • Corporate Finance
    • Financial Modelling
    • Project Finance
  • Investors
  • Merchant Bankers

    SME

    • List of SME Merchant Bankers

    MAINBOARD

    • List of Mainboard Merchant Bankers
  • Resources

    Reports

    • Daily Reporter
    • IPO Calendar
    • Mainline IPO Report
    • SME IPO Report
    • SME IPOs by Sector
    • Mainboard IPOs by Sector

    IPO Knowledge

    • IPO World Magazine
    • IPO Process
    • Pre-IPO Process Guidance
    • IPO Blogs
    • Sector Wise IPO List In India
    • List of IPO Registrar

    Notifications / Circulars

    • BSE SME Eligibility Criteria
    • SEBI ICDR Amendment Regulations March 2025
    • SEBI SME IPO ICDR Amendments report Mar–Nov 2025
    • NSE Emerge Eligibility Criteria
    • ICDR
  • News/Updates
    • Markets & Money Update
    • IPO & Market Snaps
  • Contact Us
  • Check IPO Feasibility
Check IPO Feasibility
INDIA IPO
INDIA IPO

Contact Info:

  • +91-96506-37280
  • +011-47008280
  • info@indiaipo.in
  • 808, 8thFloor D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034.
shape
  1. Home
  2. News
  3. Windlas Biotech announces Rs 47 crore buyback at Rs 1,000/share; sets April 24 as record date
ipo services in India
India IPO
  • 17 Apr 2026
  • X
 Windlas Biotech announces Rs 47 crore buyback at Rs 1,000/share; sets April 24 as record date

Windlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The move covers 2.23% equity and excludes promoters. Shares rose 2% following the announcement, reflecting positive investor sentiment toward the capital return plan.

Windlas Biotech announces Rs 47 crore buyback at Rs 1,000/share; sets April 24 as record date

Synopsis

Windlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The move covers 2.23% equity and excludes promoters. Shares rose 2% following the announcement, reflecting positive investor sentiment toward the capital return plan.

Choose your reason below and click on the Report button. This will alert our moderators to take action

Name

Reason for reporting:

Foul languageSlanderousInciting hatred against a certain communityOthers

Your Reason has been Reported to the admin.

Recent News

IPO Pipeline: Avaada Electro, Grand Housing, Sonaselection Prepare To Go Public
IPO Pipeline: Avaada Electro, Grand Housing, Sonaselection P...
19 Apr 2026
3D Glass Solutions to invest Rs 1,943 crore in Odisha for advanced chip packaging facility; Targets 2030 production
3D Glass Solutions to invest Rs 1,943 crore in Odisha for ad...
19 Apr 2026
NSE IPO: Unlisted shares crash despite offer buzz. Are late buyers locked out of OFS route?
NSE IPO: Unlisted shares crash despite offer buzz. Are late...
19 Apr 2026
What Are Value Mutual Funds? How They Work, Know Top Funds
What Are Value Mutual Funds? How They Work, Know Top Funds
19 Apr 2026
IPO-bound Acko cuts 5% workforce as AI shift reshapes roles
IPO-bound Acko cuts 5% workforce as AI shift reshapes roles
19 Apr 2026
A Sudden Twist Sends Gold Soaring & Oil Into Wild Swings, Here's What Shook Global Commodity Markets In Just One Week?
A Sudden Twist Sends Gold Soaring & Oil Into Wild Swings, He...
19 Apr 2026
13 penny stocks plunge up to 70% in CY26. Are you affected?
13 penny stocks plunge up to 70% in CY26. Are you affected?
19 Apr 2026
Neogen Chemicals Limited Completes Preferential Allotment of 10,00,000 Equity Shares to Cadamba Solutions
Neogen Chemicals Limited Completes Preferential Allotment of...
19 Apr 2026
Balanced advantage funds move in sync with markets-but not in the same way
Balanced advantage funds move in sync with markets-but not i...
19 Apr 2026
SpaceX IPO: The case for an Indian investor to go global; without going blind
SpaceX IPO: The case for an Indian investor to go global; wi...
19 Apr 2026
pre ipo advisory services in India
  • GST No: 07AAHCB7068H2ZF

India IPO is a leading Indian business services platform that helps firms and companies to launch their initial public offerings (IPOs) in order to raise essential capital for growth and expansion while adding value & fueling the nation’s immense potential and future opportunities.

Follow us:

Facebook Twitter LinkedIn Instagram YouTube

Quick Links

  • Home
  • Blogs
  • Consultant
  • Youtube Videos
  • News
  • Contact Us
  • Career

Contact Information:

  • Corporate Office: 808, 8th Floor, D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034
  • Regional Office: Office No. 601, Shagun Insignia, Ulwe, Sector-19, Navi Mumbai- 410206
  • Email: info@indiaipo.in
  • Mobile: +91-74283-37280, +91-96509-82781
  • Disclaimer  |
  • Privacy & Policy  |
  • Terms & Conditions  

Copyright © All rights reserved by - Bmarkt Tecamat Private Limited